Document is current
Any future updates will be listed below
-
Authors
Allain, Vincent
Grandin, Virginie
Meignin, Véronique
Bertinchamp, Rémi
Boutboul, David
Fieschi, Claire
Galicier, Lionel
Gérard, Laurence
Malphettes, Marion
Bustamante, Jacinta
Fusaro, Mathieu
Lambert, Nathalie
Rosain, Jérémie
Lenoir, Christelle
Kracker, Sven
Rieux-Laucat, Frédéric
Latour, Sylvain
de Villartay, Jean-Pierre
Picard, Capucine
Oksenhendler, Eric https://orcid.org/0000-0001-8588-7138
- License Information
-
More Information
Article History
Received: 5 July 2022
Accepted: 14 September 2022
First Online: 26 September 2022
Declarations
:
: The DEFI study was approved by an ethical committee [RBM0333].
: All patients gave written informed consent.
: All authors have reviewed the manuscript and agreed for publication.
: VA, VG, VM, RB, DB, CF, LGé, MM, JB, MF, NL, JR, CL, SK, FRL, SL, JPV, and CP declare that they have no relevant conflicts of interest. LGa serves as a consultant for Novartis Pharma SAS and Sanofi Aventis France. EO serves as a consultant for EusaPharma and CSL Behring.
